 Bloomberg | FDA approves Novartis drug Afinitor for breast cancer Reuters India The drug is the first in a class known as mTOR inhibitors to be approved for post-menopausal women with advanced hormone-receptor positive, HER2-negative breast cancer. Afinitor, also known as everolimus, is designed to be given in combination with ... Novartis gains FDA approval for AfinitorR in advanced breast cancer marking a ... Novartis gains FDA approval for Afinitor® in advanced breast cancer marking a ... FDA approves Afinitor for advanced breast cancer |
